Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D) | MicrobiomeTrials← Back to trialsNCT07639684
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2027-02Est. Completion: 2029-05
Enrollment target: 50 participants Other microbiome trials you might be interested in
HypertensionDiabetes
Background:
* Type 2 diabetes (T2D) and associated complications are major contributors to the global disease burden. T…
Accra, Ghana
Type2 Diabetes Mellitus
In this study the primary aims are to investigate the effect of resistance exercise training with different degrees of e…
Albuquerque, United StatesEst. completion Jul 30, 2026
Fatty Liver
The newly adapted definition for MASLD includes evidence for hepatic steatosis by imaging or biopsy with at least one of…
Sohag, EgyptEst. completion Jan 1, 2027